Ambrose Kristen 4

What Happened

• Kristen Ambrose, Senior Vice President and Chief Accounting Officer of Vertex Pharmaceuticals (VRTX), had 1,393 shares disposed/withheld to cover tax liability on 2026-02-13. The per-share amount listed is $487.76, for a total value of approximately $679,450.

Key Details

• Transaction date: 2026-02-13; Form 4 filed: 2026-02-18.
• Transaction type/code: "F" — payment of exercise price or tax liability (shares withheld to cover taxes).
• Shares disposed: 1,393 at $487.76; total value ≈ $679,450.
• Shares owned after the transaction: not specified in the provided filing summary.
• No late-filing flag (transactionTimeliness = 'L') was noted in the information you provided.

Context

• Code F typically means shares were retained/withheld to satisfy tax withholding obligations after an equity award vested or options were exercised (a routine, administrative action). This is not the same as an open-market sale and does not necessarily indicate the insider is selling to realize gains or expressing a view on the company’s prospects.